|
bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream
|
|
|
|
Clinical Study Confirms Exceptional Performance and High Tolerability
|
|
Knokke-Heist (Belgium), 8 April 2025, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), a leader in dental consumer goods and professional dental consumables, announces that it has successfully advanced to Phase 3 in the development of its innovative Alginate-Organic Olive-oil based Denture Fixative Cream following a positive clinical-dermatological application study conducted by Dermatest GmbH (Germany).
|
|
The study assessed the product’s efficacy and safety after daily application over five consecutive days by healthy denture wearers.
|
|
The primary objective of the study was to evaluate the retention, stability, and functional benefits of the Alginate-Organic Olive-oil based Denture Fixative Cream while also investigating its tolerability according to stringent clinical-dermatological test criteria.
|
|
The results were highly encouraging, demonstrating that Alginate-Organic Olive-oil based Denture Fixative Cream significantly improves masticatory ability and provides long-lasting retention for upper dentures, with holding times of up to 24 hours when applied according to instructions.
|
|
Additionally, the study confirmed the excellent tolerability of the product. All participants completed the five-day application period without experiencing any adverse reactions, such as irritation or allergic responses.
|
|
These findings underscore the unique positioning of bonyf’s Alginate-Organic Olive-oil based Denture Fixative Cream as a superior solution in the market—offering both extended hold performance and a healthy, organic-based formulation.
|
|
“The successful outcome of this study is a significant milestone for bonyf, as we continue our mission to develop cutting-edge solutions that enhance the well-being of denture wearers”, said CEO, Jean-Pierre Bogaert.
|
|
bonyf remains committed to innovation and plans to accelerate preparations for market launch, with Alginate-Organic Olive-oil based Denture Fixative Cream poised to set a new standard in denture care.
|
|
For more information, visit bonyf.com or contact investor@bonyf.com.
|
|
bonyf’s strengths
- Products with patented formulations
- Produced in Switzerland compliant with stringent international quality regulations
- Proven clinical efficacy
- Commercial presence in 37 countries
- Prospects for solid growth and rapid profitability
- A fast-growing oral and dental care market
|
|
|
|
About bonyf
Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. bonyf is a forward-thinking company committed to revolutionizing oral care through innovation and research. With a focus on quality and efficacy, bonyf develops cutting-edge products designed to enhance the well-being of individuals worldwide. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market.
For more information about bonyf and its innovative oral care products, please visit www.bonyf.com.
|
|
bonyf
Jean-Pierre Bogaert
investor@bonyf.com
|
|
